Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma.

Szaumkessel M, Richter J, Giefing M, Jarmuz M, Kiwerska K, Tönnies H, Grenman R, Heidemann S, Szyfter K, Siebert R.

Int J Oncol. 2011 Aug;39(2):505-14. doi: 10.3892/ijo.2011.1039. Epub 2011 May 11.

PMID:
21567085
2.

The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.

Barroso E, Pita G, Arias JI, Menendez P, Zamora P, Blanco M, Benitez J, Ribas G.

Breast Cancer Res Treat. 2009 Dec;118(3):655-60. doi: 10.1007/s10549-009-0439-5. Epub 2009 Jun 18.

PMID:
19536649
3.

Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.

Hess CJ, Ameziane N, Schuurhuis GJ, Errami A, Denkers F, Kaspers GJ, Cloos J, Joenje H, Reinhardt D, Ossenkoppele GJ, Zwaan CM, Waisfisz Q.

Cell Oncol. 2008;30(4):299-306.

4.

Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers.

Smith IM, Mithani SK, Mydlarz WK, Chang SS, Califano JA.

ORL J Otorhinolaryngol Relat Spec. 2010;72(1):44-50. doi: 10.1159/000292104. Epub 2010 Mar 24.

5.
6.

Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.

Guénard F, Labrie Y, Ouellette G, Joly Beauparlant C, Simard J, Durocher F; INHERIT BRCAs.

J Hum Genet. 2008;53(7):579-91. doi: 10.1007/s10038-008-0285-z. Epub 2008 Apr 15.

PMID:
18414782
7.

Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.

García MJ, Fernández V, Osorio A, Barroso A, Fernández F, Urioste M, Benítez J.

Carcinogenesis. 2009 Nov;30(11):1898-902. doi: 10.1093/carcin/bgp218. Epub 2009 Sep 8.

PMID:
19737859
8.

Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.

Chandrasekharappa SC, Chinn SB, Donovan FX, Chowdhury NI, Kamat A, Adeyemo AA, Thomas JW, Vemulapalli M, Hussey CS, Reid HH, Mullikin JC, Wei Q, Sturgis EM.

Cancer. 2017 Oct 15;123(20):3943-3954. doi: 10.1002/cncr.30802. Epub 2017 Jul 5.

PMID:
28678401
9.

Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.

Szaumkessel M, Wojciechowska S, Janiszewska J, Zemke N, Byzia E, Kiwerska K, Kostrzewska-Poczekaj M, Ustaszewski A, Jarmuz-Szymczak M, Grenman R, Wierzbicka M, Bartochowska A, Szyfter K, Giefing M.

Tumour Biol. 2017 Mar;39(3):1010428317691427. doi: 10.1177/1010428317691427.

PMID:
28345455
10.

Utility of MS-MLPA in DNA methylation profiling in primary laryngeal squamous cell carcinoma.

López F, Sampedro T, Llorente JL, Domínguez F, Hermsen M, Suárez C, Alvarez-Marcos C.

Oral Oncol. 2014 Apr;50(4):291-7. doi: 10.1016/j.oraloncology.2014.01.003. Epub 2014 Jan 18.

PMID:
24444674
11.

Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.

Wang W.

Nat Rev Genet. 2007 Oct;8(10):735-48. Epub 2007 Sep 4. Review.

PMID:
17768402
12.
13.

Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.

Paluszczak J, Hemmerling D, Kostrzewska-Poczekaj M, Jarmuż-Szymczak M, Grenman R, Wierzbicka M, Baer-Dubowska W.

J Oral Pathol Med. 2014 Oct;43(9):652-7. doi: 10.1111/jop.12178. Epub 2014 Apr 25.

PMID:
24762262
14.

Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.

Hussain S, Witt E, Huber PA, Medhurst AL, Ashworth A, Mathew CG.

Hum Mol Genet. 2003 Oct 1;12(19):2503-10. Epub 2003 Aug 5.

PMID:
12915460
15.

Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.

Godthelp BC, van Buul PP, Jaspers NG, Elghalbzouri-Maghrani E, van Duijn-Goedhart A, Arwert F, Joenje H, Zdzienicka MZ.

Mutat Res. 2006 Oct 10;601(1-2):191-201. Epub 2006 Aug 21.

PMID:
16920162
16.

Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.

Shen X, Do H, Li Y, Chung WH, Tomasz M, de Winter JP, Xia B, Elledge SJ, Wang W, Li L.

Mol Cell. 2009 Sep 11;35(5):716-23. doi: 10.1016/j.molcel.2009.06.034.

17.

Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival.

Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT.

Oncogene. 2004 Jan 29;23(4):1000-4.

PMID:
14647419
18.

Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.

Litim N, Labrie Y, Desjardins S, Ouellette G, Plourde K, Belleau P; INHERIT BRCAs, Durocher F.

Mol Oncol. 2013 Feb;7(1):85-100. doi: 10.1016/j.molonc.2012.08.002. Epub 2012 Sep 11.

19.

The Fanconi anemia pathway of genomic maintenance.

Levitus M, Joenje H, de Winter JP.

Cell Oncol. 2006;28(1-2):3-29. Review.

20.

Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia.

Tischkowitz MD, Morgan NV, Grimwade D, Eddy C, Ball S, Vorechovsky I, Langabeer S, Stöger R, Hodgson SV, Mathew CG.

Leukemia. 2004 Mar;18(3):420-5.

PMID:
14749703

Supplemental Content

Support Center